Alpha 2.0
Login Register
» Articles » PMID: 8784059

Monoclonal, Human Autoantibodies to the TSH Receptor--the Holy Grail and Why Are We Looking for It?

Overview
Journal J Clin Endocrinol Metab
Publisher Oxford University Press
Specialty Endocrinology
Date 1996 Sep 1
PMID 8784059
Citations 4
Authors
S M McLachlan
B Rapoport
Affiliations
Soon will be listed here.
Citing Articles

Blocking type TSH receptor antibodies.

Furmaniak J, Sanders J, Rees Smith B Auto Immun Highlights. 2015; 4(1):11-26.

PMID: 26000138 PMC: 4389084. DOI: 10.1007/s13317-012-0028-1.

Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.

Chazenbalk G, Pichurin P, Chen C, Latrofa F, Johnstone A, McLachlan S J Clin Invest. 2002; 110(2):209-17.

PMID: 12122113 PMC: 151066. DOI: 10.1172/JCI15745.

Thyroid autoimmunity.

Rapoport B, McLachlan S J Clin Invest. 2001; 108(9):1253-9.

PMID: 11696565 PMC: 209450. DOI: 10.1172/JCI14321.

Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.

Van Der Heijden J, de Bruin T, Glaudemans K, de Kruif J, Banga J, Logtenberg T Clin Exp Immunol. 1999; 118(2):205-12.

PMID: 10540180 PMC: 1905415. DOI: 10.1046/j.1365-2249.1999.01042.x.